Analysen von Jo Walton
| 28.04.25 | Sanofi Buy | UBS AG | |
| 28.04.25 | Novo Nordisk Buy | UBS AG | |
| 25.04.25 | Sanofi Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | UBS AG | |
| 17.04.25 | Sanofi Buy | UBS AG | |
| 08.04.25 | Novo Nordisk Buy | UBS AG | |
| 07.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | Novo Nordisk Buy | UBS AG | |
|
Werbung
|
|||
| 31.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 21.03.25 | Novo Nordisk Buy | UBS AG | |
| 17.03.25 | Novo Nordisk Buy | UBS AG | |
| 14.03.25 | Novo Nordisk Buy | UBS AG | |
| 10.03.25 | Novo Nordisk Buy | UBS AG | |
| 07.03.25 | Bayer Neutral | UBS AG | |
| 07.03.25 | Novo Nordisk Buy | UBS AG | |
| 06.03.25 | Bayer Neutral | UBS AG | |
| 03.03.25 | Novo Nordisk Buy | UBS AG | |
| 25.02.25 | Bayer Neutral | UBS AG | |
| 24.02.25 | Novo Nordisk Buy | UBS AG | |
| 17.02.25 | Novo Nordisk Buy | UBS AG | |
| 13.02.25 | Sanofi Buy | UBS AG | |
| 10.02.25 | Novo Nordisk Buy | UBS AG | |
| 07.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | GSK Neutral | UBS AG | |
| 05.02.25 | GSK Neutral | UBS AG | |
| 05.02.25 | Novo Nordisk Buy | UBS AG | |
| 03.02.25 | Novo Nordisk Buy | UBS AG | |
| 03.02.25 | Sanofi Buy | UBS AG | |
| 31.01.25 | Sanofi Buy | UBS AG | |
| 30.01.25 | GSK Neutral | UBS AG | |
| 30.01.25 | Sanofi Buy | UBS AG | |
| 29.01.25 | Novo Nordisk Buy | UBS AG | |
| 28.01.25 | Novo Nordisk Buy | UBS AG | |
| 24.01.25 | Novo Nordisk Buy | UBS AG | |
| 23.01.25 | Sanofi Buy | UBS AG | |
| 21.01.25 | Novo Nordisk Buy | UBS AG | |
| 17.01.25 | Novo Nordisk Buy | UBS AG | |
| 16.01.25 | Novo Nordisk Buy | UBS AG | |
| 13.01.25 | Novo Nordisk Buy | UBS AG | |
| 08.01.25 | Novo Nordisk Buy | UBS AG | |
| 20.12.24 | Novo Nordisk Neutral | UBS AG | |
| 16.12.24 | Novo Nordisk Neutral | UBS AG | |
| 09.12.24 | Novo Nordisk Neutral | UBS AG | |
| 02.12.24 | Novo Nordisk Neutral | UBS AG | |
| 21.11.24 | Bayer Neutral | UBS AG | |
| 18.11.24 | Novo Nordisk Neutral | UBS AG | |
| 13.11.24 | Bayer Neutral | UBS AG | |